Clinical Results Of Smile Pro Using Corneal Apex And Cyclotorsion-Guided Lenticule Centration
Published 2026 - 44th Congress of the ESCRS
Reference: POREF106 | Type: Free paper | DOI: 10.82333/9gce-m883
Authors: Dr Olesia Ziiatdinova* 1 , Dr Chun chun He 1 , Dr Lina Zhou 1
1Euroeyes ,Beijing ,China
Purpose
Evaluating SMILE PRO Outcomes with Apex- and Cyclotorsion-Guided Centration in Myopic Astigmatism
Setting
Patient Demographics & Preoperative Data
(n=50 eyes)
Procedure: SMILE PRO for myopic astigmatism
Mean Age: 27 ± 4.2 years
Mean Corneal Thickness: 525.3 ± 21.8 µm
Preoperative Refractive Range:
Sphere: -1.5 to -6.0 D
Astigmatism: 1.5 to 3.5 D
Methods
Preoperative lenticule centration parameters were imported
to the laser treatment software using Pentacam and
IOLMaster 700.
The minimal shift between Pentacam and IOLMaster
relative the pupil center was selected.
Performed under slit-lamp examination.
• A disposable sterile skin marker was used.
• A horizontal reference line and two corneal
reference points were placed.
• Points were positioned 2-3 mm from the
limbus.
Results
Follow-up Schedule: 1 day, 1 week, 1 month, 3 months
(Measures: Autorefraction, UCVA, MCVA)
1-Week Follow-up:
UCVA ≥ Preop MCVA: 98.3% of eyes
Mean Spherical Equivalent (SE): +0.28 ± 0.29 D
Mean Manifest Sphere: +0.30 ± 0.31 D
Mean Residual Astigmatism: +0.32 ± 0.24 D
Postoperative data
1-Month Follow-Up
Visual Recovery: 98.7% of eyes achieved UCVA ≥
Preoperative MCVA.
Mean Spherical Equivalent (SE): +0.18 ± 0.22 D
Mean Manifest Sphere: +0.20 ± 0.24 D
Mean Residual Astigmatism: +0.25 ± 0.20 D
3-Month Follow-Up
Visual Recovery: 98.9% of eyes achieved UCVA ≥
Preoperative MCVA.
Mean Spherical Equivalent (SE): +0.15 ± 0.20 D
Mean Manifest Sphere: +0.17 ± 0.22 D
Mean Residual Astigmatism: +0.22 ± 0.28 D
Conclusions
The SMILE PRO procedure with apex- and cyclotorsion-
guided centration achieved targeted visual outcomes with high
refractive accuracy at 3 months.
This dual-guidance approach demonstrated excellent efficacy
and safety for correcting myopia and myopic astigmatism.
Further prospective follow-up is ongoing to confirm long-
term stability